Adjustment on the Type I Error Rate for a Clinical Trial Monitoring for both Intermediate and Primary Endpoints.
暂无分享,去创建一个
[1] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[2] Christopher Jennison,et al. Interim analyses: the repeated confidence interval approach , 1989 .
[3] Richard Pazdur,et al. End points and United States Food and Drug Administration approval of oncology drugs. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Sklar. Fonctions de repartition a n dimensions et leurs marges , 1959 .
[5] Martin T. Wells,et al. Model Selection and Semiparametric Inference for Bivariate Failure-Time Data , 2000 .
[6] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[7] Susan Todd,et al. An Adaptive Approach to Implementing Bivariate Group Sequential Clinical Trial Designs , 2003, Journal of biopharmaceutical statistics.
[8] E. Lakatos,et al. Designing complex group sequential survival trials. , 2002, Statistics in medicine.
[9] Anastasios A. Tsiatis,et al. Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis , 1994 .
[10] William Berry,et al. Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] B W Turnbull,et al. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints. , 1993, Biometrics.
[12] P. Sen,et al. Copulas: concepts and novel applications , 2003 .
[13] Richard Pazdur,et al. Accelerated approval of oncology products: a decade of experience. , 2004, Journal of the National Cancer Institute.
[14] J Whitehead,et al. Sequential methods based on the boundaries approach for the clinical comparison of survival times. , 1994, Statistics in medicine.
[15] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[16] H. Joe. Multivariate Models and Multivariate Dependence Concepts , 1997 .
[17] R J Cook,et al. Guidelines for monitoring efficacy and toxicity responses in clinical trials. , 1994, Biometrics.